BR9912533A - Composição farmacêutica tendo sabor melhorado - Google Patents

Composição farmacêutica tendo sabor melhorado

Info

Publication number
BR9912533A
BR9912533A BR9912533-1A BR9912533A BR9912533A BR 9912533 A BR9912533 A BR 9912533A BR 9912533 A BR9912533 A BR 9912533A BR 9912533 A BR9912533 A BR 9912533A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
drug
improved taste
improved
taste
Prior art date
Application number
BR9912533-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Yoshinao Onishi
Hirofumi Doi
Masaaki Odomi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR9912533A publication Critical patent/BR9912533A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BR9912533-1A 1998-07-31 1999-07-26 Composição farmacêutica tendo sabor melhorado BR9912533A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21751798 1998-07-31
PCT/JP1999/004046 WO2000006122A1 (fr) 1998-07-31 1999-07-26 Composition pharmaceutique ayant un gout ameliore

Publications (1)

Publication Number Publication Date
BR9912533A true BR9912533A (pt) 2002-02-13

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912533-1A BR9912533A (pt) 1998-07-31 1999-07-26 Composição farmacêutica tendo sabor melhorado

Country Status (10)

Country Link
EP (1) EP1100466A1 (fr)
KR (1) KR20010072151A (fr)
CN (1) CN1161106C (fr)
AR (1) AR019485A1 (fr)
AU (1) AU4802699A (fr)
BR (1) BR9912533A (fr)
CA (1) CA2338996A1 (fr)
HK (1) HK1040191A1 (fr)
ID (1) ID28910A (fr)
WO (1) WO2000006122A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207932A (pt) 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas de sabor mascarado
MXPA03008056A (es) 2001-03-05 2004-10-15 Johnson & Johnson Composiciones farmaceuticas liquidas con sabor oculto.
ATE454906T1 (de) * 2003-07-11 2010-01-15 Astrazeneca Ab Feste zusammensetzung mit einem protonenpumpenhemmer
CN100435847C (zh) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 含有难溶解性主药之持续释放配方
CN1964699B (zh) 2004-06-07 2010-12-08 株式会社吴羽 干燥形态经口摄取用组合物和用时调制型凝胶状经口摄取用组合物
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
WO2011149814A2 (fr) * 2010-05-24 2011-12-01 Amerilab Technologies, Inc. Composition effervescente pour la formation d'une composition gélifiée, comprimé pour la formation d'une composition gélifiée et procédé de fabrication d'une composition gélifiée
CA2847614C (fr) * 2011-09-30 2018-10-23 Mochida Pharmaceutical Co., Ltd. Preparation solide facile a prendre
KR102555664B1 (ko) * 2017-02-21 2023-07-18 이에이 파마 가부시키가이샤 과립 제제
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
EP0826376B1 (fr) * 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition s'administrant par voie orale
PT841062E (pt) * 1995-07-21 2005-03-31 Daiichi Seiyaku Co Processo para a producao de uma preparacao granular
CA2227314A1 (fr) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Fabrication de preparations a saveur dissimulee contenant des derives de quinolones actifs du point de vue antibacterien

Also Published As

Publication number Publication date
EP1100466A1 (fr) 2001-05-23
KR20010072151A (ko) 2001-07-31
AR019485A1 (es) 2002-02-20
CN1161106C (zh) 2004-08-11
CA2338996A1 (fr) 2000-02-10
ID28910A (id) 2001-07-12
WO2000006122A1 (fr) 2000-02-10
HK1040191A1 (zh) 2002-05-31
AU4802699A (en) 2000-02-21
CN1316899A (zh) 2001-10-10

Similar Documents

Publication Publication Date Title
NZ501950A (en) Medicinal compositions for application to mucosa
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
DK0696921T3 (da) Veterinært præparat indeholdende en protonpumpeinhibitor
HUP0302114A2 (hu) Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása
DE69928554D1 (de) Therapeutische formulierung enthaltende dosierungsform
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
GB9808796D0 (en) Antithrombotic agents
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
AR017512A1 (es) Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
HUP0101411A2 (hu) 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása
ATE243504T1 (de) Cefadroxilmonohydrat tablettenformulierung
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
HUP0201631A2 (hu) Alkalikus szfingomielinázt tartalmazó dietetikus készítmények, ételkiegészítők és gyógyászati termékek
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
HUP9900507A2 (hu) Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmények előállítására
SE8703632D0 (sv) Sustained release fluoride composition
HUP0000125A2 (hu) Folyékony alendronátkészítmények, valamint eljárás azok előállítására
FR2500303B1 (fr)
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1919 DE 16/10/2007.